
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
RXRβ CRISPR/Cas9 KO Plasmid (m) | sc-422768 | 20 µg | $397.00 |
Rxrb encodes retinoid X receptor beta (RXRβ), a ligand-activated nuclear receptor that forms heterodimers with multiple partners including PPARs, LXRs, FXR, VDR, and RARs to regulate transcriptional programs controlling lipid and glucose metabolism, cell differentiation, and inflammatory signaling. RXRβ integrates retinoid and lipid-derived cues to modulate chromatin-associated transcription at response elements, influencing mitochondrial function and oxidative balance in metabolically active tissues. In mouse models, altered Rxrb activity has been linked to dysregulated metabolic homeostasis and immune modulation, making it relevant to studies of steatosis, insulin sensitivity, and inflammatory disease mechanisms. Its central role in nuclear receptor crosstalk also positions RXRβ as a node for dissecting pathway interactions in development and endocrine signaling.
RXRβ CRISPR/Cas9 KO Plasmid (m) is a pool of plasmids designed for targeted disruption of the Rxrb gene in mouse cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the Rxrb together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the Rxrb open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish RXRβ protein expression.
This CRISPR knockout system enables efficient generation of Rxrb-deficient cell models for investigation of RXRβ signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.